Clinical Trial
Albuterol and ephedrine in patients with reversible obstructive airway disease
- PMID: 326102
Item in Clipboard
Clinical Trial
Albuterol and ephedrine in patients with reversible obstructive airway disease
Ann Allergy.
1977 Jun.
Abstract
This study evaluated the cardiac, pulmonary and neuromuscular effects of albuterol and ephedrine. The pulmonary effects of albuterol occurred earlier, lasted longer and were greater in degree. The cardiac effects of both drugs were virtually non-existent. Tremor was recorded with the higher doses of albuterol.
Similar articles
-
Bronchodilatory and circulatory effects of two doses of a beta2-agonist (terbutaline) inhaled with IPPB in patients with reversible airways obstruction.Scand J Respir Dis. 1976;57(5):252-8. Scand J Respir Dis. 1976. PMID: 792994 Clinical Trial.
-
A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.Arch Intern Med. 1989 Mar;149(3):544-7. Arch Intern Med. 1989. PMID: 2521997 Clinical Trial.
-
A comparative trial of pirbuterol and Tedral in patients with reversible airway obstruction.Ann Allergy. 1979 Dec;43(6):348-51. Ann Allergy. 1979. PMID: 391108 Clinical Trial. No abstract available.
-
Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease.Postgrad Med J. 1977;53 Suppl 3:143-8. Postgrad Med J. 1977. PMID: 22070 Clinical Trial. No abstract available.
-
Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.Br J Dis Chest. 1980 Jan;74(1):70-7. Br J Dis Chest. 1980. PMID: 6101961 Clinical Trial.